Valuation SCI Pharmtech, Inc.

Stocks

End-of-day quote Taiwan S.E. 2026-10-29			5-day change	1st Jan Change
51.60 ^TWD	-2.64%		-2.46%	+5.95%

08-06	SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-07	SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	6,677	8,012	9,300	11,568	10,827	5,820
Change	-	20%	16.07%	24.39%	-6.4%	-46.25%
Enterprise Value (EV) ¹	6,046	7,322	9,581	11,580	11,125	6,732
Change	-	21.09%	30.86%	20.87%	-3.93%	-39.48%
P/E	18.7x	145x	30.2x	36x	20.3x	54.2x
PBR	2.01x	2.41x	2.56x	2.27x	1.98x	1.08x
PEG	-	-1.7x	0x	-5.71x	0.3x	-0.7x
Capitalization / Revenue	2.48x	9.27x	10.3x	9.61x	7.11x	4.33x
EV / Revenue	2.25x	8.47x	10.6x	9.62x	7.3x	5.01x
EV / EBITDA	5.11x	54x	46.1x	38.1x	25.9x	16.7x
EV / EBIT	5.75x	99.4x	80.5x	72.2x	56.1x	43.4x
EV / FCF	8.15x	-16x	-8.22x	-9.67x	-27.6x	-11.9x
FCF Yield	12.3%	-6.26%	-12.2%	-10.3%	-3.62%	-8.43%
Dividend per Share ²	0.3704	-	0.2222	1.25	1.5	0.75
Rate of return	0.6%	-	0.26%	1.29%	1.66%	1.54%
EPS ²	3.326	0.5156	2.871	2.69	4.46	0.8985
Distribution rate	11.1%	-	7.74%	46.5%	33.6%	83.5%
Net sales ¹	2,689	864.2	899.7	1,204	1,524	1,344
EBITDA ¹	1,183	135.6	207.9	303.7	429.7	402.4
EBIT ¹	1,052	73.66	119	160.3	198.3	155.2
Net income ¹	360.1	55.7	308.8	294.7	534.7	107.4
Net Debt ¹	-630.4	-690.5	281	11.42	297.6	912.4
Reference price ²	62.22	74.67	86.67	96.80	90.60	48.70
Nbr of stocks (in thousands)	107,305	107,305	107,305	119,509	119,509	119,509
Announcement Date	3/26/21	3/22/22	3/21/23	3/20/24	3/12/25	3/13/26

¹TWD in Million²TWD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SCI PHARMTECH, INC.	-	-	-	-	195M
ELI LILLY AND COMPANY	37.84x	13.27x	28.43x	0.53%	1,148B
JOHNSON & JOHNSON	39.67x	6.67x	18.75x	1.97%	652B
ABBVIE INC.	37.4x	8.39x	17.35x	2.4%	505B
ROCHE HOLDING AG	21.45x	5.21x	12.93x	2.51%	384B
MERCK & CO., INC.	102.73x	5.76x	24.72x	2.42%	348B
NOVARTIS AG	21.89x	5.76x	13.88x	2.85%	294B
ASTRAZENECA PLC	22.21x	4.49x	12.82x	1.97%	264B
AMGEN INC.	28.66x	7.33x	13.12x	2.23%	244B
GILEAD SCIENCES, INC.	-45.79x	7.11x	27.55x	2.07%	197B
Average	29.56x	7.11x	18.84x	2.11%	403.74B
Weighted average by Cap.	35.29x	8.40x	20.64x	1.79%